Cargando…
Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335942/ https://www.ncbi.nlm.nih.gov/pubmed/37306840 http://dx.doi.org/10.1007/s11239-023-02841-7 |
| _version_ | 1785071103185518592 |
|---|---|
| author | Sutton, S. Scott Magagnoli, Joseph Cummings, Tammy H. Dettling, Theresa Lovelace, Belinda Christoph, Mary J. Hardin, James W. |
| author_facet | Sutton, S. Scott Magagnoli, Joseph Cummings, Tammy H. Dettling, Theresa Lovelace, Belinda Christoph, Mary J. Hardin, James W. |
| author_sort | Sutton, S. Scott |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10335942 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103359422023-07-13 Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate Sutton, S. Scott Magagnoli, Joseph Cummings, Tammy H. Dettling, Theresa Lovelace, Belinda Christoph, Mary J. Hardin, James W. J Thromb Thrombolysis Publisher Correction Springer US 2023-06-12 2023 /pmc/articles/PMC10335942/ /pubmed/37306840 http://dx.doi.org/10.1007/s11239-023-02841-7 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Publisher Correction Sutton, S. Scott Magagnoli, Joseph Cummings, Tammy H. Dettling, Theresa Lovelace, Belinda Christoph, Mary J. Hardin, James W. Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate |
| title | Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate |
| title_full | Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate |
| title_fullStr | Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate |
| title_full_unstemmed | Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate |
| title_short | Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate |
| title_sort | correction to: real-world clinical outcomes among us veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335942/ https://www.ncbi.nlm.nih.gov/pubmed/37306840 http://dx.doi.org/10.1007/s11239-023-02841-7 |
| work_keys_str_mv | AT suttonsscott correctiontorealworldclinicaloutcomesamongusveteranswithoralfactorxainhibitorrelatedmajorbleedingtreatedwithandexanetalfaor4factorprothrombincomplexconcentrate AT magagnolijoseph correctiontorealworldclinicaloutcomesamongusveteranswithoralfactorxainhibitorrelatedmajorbleedingtreatedwithandexanetalfaor4factorprothrombincomplexconcentrate AT cummingstammyh correctiontorealworldclinicaloutcomesamongusveteranswithoralfactorxainhibitorrelatedmajorbleedingtreatedwithandexanetalfaor4factorprothrombincomplexconcentrate AT dettlingtheresa correctiontorealworldclinicaloutcomesamongusveteranswithoralfactorxainhibitorrelatedmajorbleedingtreatedwithandexanetalfaor4factorprothrombincomplexconcentrate AT lovelacebelinda correctiontorealworldclinicaloutcomesamongusveteranswithoralfactorxainhibitorrelatedmajorbleedingtreatedwithandexanetalfaor4factorprothrombincomplexconcentrate AT christophmaryj correctiontorealworldclinicaloutcomesamongusveteranswithoralfactorxainhibitorrelatedmajorbleedingtreatedwithandexanetalfaor4factorprothrombincomplexconcentrate AT hardinjamesw correctiontorealworldclinicaloutcomesamongusveteranswithoralfactorxainhibitorrelatedmajorbleedingtreatedwithandexanetalfaor4factorprothrombincomplexconcentrate |